Skip to main content
Log in

NHG-Standaard Cardiovasculair risicomanagement (2)

  • Ingezonden
  • Published:
Huisarts en Wetenschap Aims and scope

Samenvatting

Als medewerker van een aanbevelingsgroep cardiovasculair risicobeheer van de Vlaamse Domus Medica (vroeger WVVH) heb ik een vraag over het al of niet adviseren tot gebruik van ASA bij hoog risico patiënten, zonder HVZ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatuur

  • Ridker PM, Cook NR, Lee IM, Gordon BSD, Gaziano JM, Manson JE, et al. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women. N Engl J Med 2005;352:1293-1304.

    Article  CAS  PubMed  Google Scholar 

  • Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-13.

    Article  CAS  PubMed  Google Scholar 

  • Hung J. Aspirin for primary prevention of cardiovascular disease in women: does sex matter? Med J Australia 2006;184:260-1.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

 ,  . NHG-Standaard Cardiovasculair risicomanagement (2). HUWE 49, 530–531 (2006). https://doi.org/10.1007/BF03084813

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03084813

Navigation